XML 124 R105.htm IDEA: XBRL DOCUMENT v3.24.1.u1
Supplemental Financial Information - Cash Flows (Details) - USD ($)
$ in Millions
 3 Months Ended
Mar. 31, 2024
Mar. 31, 2023
Dec. 31, 2023
Cash flows from operating activities      
Net income $ 98.8 $ 125.3  
Adjustments to reconcile net income to net cash flows from operating activities:      
Depreciation and amortization 45.3 44.0  
Equity-based compensation 108.3 54.4  
Non-cash performance allocations and incentive fees, net 190.9 (36.7)  
Non-cash principal investment income (70.0) (7.7)  
Other non-cash amounts (2.9) 10.8  
Purchases of investments (145.1) (18.5)  
Proceeds from the sale of investments 102.1 78.6  
Payments of contingent consideration (1.5) (68.6)  
Changes in deferred taxes, net (47.1) (15.1)  
Change in due from affiliates and other receivables 6.7 16.9  
Change in deposits and other (19.7) (33.9)  
Change in accounts payable, accrued expenses and other liabilities 41.5 (63.9)  
Change in accrued compensation and benefits (365.6) (371.9)  
Change in due to affiliates (2.2) (0.2)  
Change in lease right-of-use asset and lease liability (2.2) (2.8)  
Change in deferred revenue 251.6 284.7  
Net cash provided by (used in) operating activities 71.1 (112.5)  
Cash flows from investing activities      
Purchases of corporate treasury investments 0.0 (101.1)  
Proceeds from corporate treasury investments 0.0 20.1  
Purchases of fixed assets, net (14.2) (12.9)  
Net cash used in investing activities (14.2) (93.9)  
Cash flows from financing activities      
Payments on CLO borrowings (13.9) (1.1)  
Dividends to common stockholders (126.7) (118.4)  
Payment of deferred consideration for Carlyle Holdings units (68.8) (68.8)  
Contributions from non-controlling interest holders 64.7 18.7  
Distributions to non-controlling interest holders (19.0) (9.9)  
Common shares repurchased and net share settlement of equity awards (150.0) (100.3)  
Change in due to/from affiliates financing activities 51.7 74.6  
Net cash used in financing activities (216.7) (136.5)  
Effect of foreign exchange rate changes (4.4) 8.3  
Decrease in cash, cash equivalents and restricted cash (164.2) (334.6)  
Cash, cash equivalents and restricted cash, beginning of period 1,442.1 1,361.5  
Cash, cash equivalents and restricted cash, end of period 1,277.9 1,026.9  
Reconciliation of cash, cash equivalents and restricted cash, end of period:      
Cash and cash equivalents 1,276.5 1,010.1 $ 1,440.3
Restricted cash 1.4 16.8 1.8
Total cash, cash equivalents and restricted cash, end of period 1,277.9 1,026.9 1,442.1
Cash and cash equivalents held at Consolidated Funds 426.0 228.8 346.0
Consolidated Operating Entities      
Cash flows from operating activities      
Net income 86.1 108.1  
Adjustments to reconcile net income to net cash flows from operating activities:      
Depreciation and amortization 45.3 44.0  
Equity-based compensation 108.3 54.4  
Non-cash performance allocations and incentive fees, net 189.6 (38.2)  
Non-cash principal investment income (68.1) (8.7)  
Other non-cash amounts (2.9) 10.8  
Purchases of investments (215.1) (19.0)  
Proceeds from the sale of investments 108.3 78.9  
Payments of contingent consideration (1.5) (68.6)  
Changes in deferred taxes, net (47.1) (15.1)  
Change in due from affiliates and other receivables 7.9 17.0  
Change in deposits and other (19.7) (33.9)  
Change in accounts payable, accrued expenses and other liabilities 41.5 (63.9)  
Change in accrued compensation and benefits (365.6) (371.9)  
Change in due to affiliates (2.2) (0.2)  
Change in lease right-of-use asset and lease liability (2.2) (2.8)  
Change in deferred revenue 251.6 284.7  
Net cash provided by (used in) operating activities 114.2 (24.4)  
Cash flows from investing activities      
Purchases of corporate treasury investments 0.0 (101.1)  
Proceeds from corporate treasury investments 0.0 20.1  
Purchases of fixed assets, net (14.2) (12.9)  
Net cash used in investing activities (14.2) (93.9)  
Cash flows from financing activities      
Payments on CLO borrowings (13.9) (1.1)  
Proceeds from CLO borrowings, net of financing costs 0.0 0.0  
Dividends to common stockholders (126.7) (118.4)  
Payment of deferred consideration for Carlyle Holdings units (68.8) (68.8)  
Contributions from non-controlling interest holders 62.5 2.0  
Distributions to non-controlling interest holders (19.0) (8.5)  
Common shares repurchased and net share settlement of equity awards (150.0) (100.3)  
Change in due to/from affiliates financing activities 56.7 73.0  
Net cash used in financing activities (259.2) (222.1)  
Effect of foreign exchange rate changes (5.0) 5.8  
Decrease in cash, cash equivalents and restricted cash (164.2) (334.6)  
Cash, cash equivalents and restricted cash, beginning of period 1,442.1 1,361.5  
Cash, cash equivalents and restricted cash, end of period 1,277.9 1,026.9  
Reconciliation of cash, cash equivalents and restricted cash, end of period:      
Cash and cash equivalents 1,276.5 1,010.1  
Restricted cash 1.4 16.8  
Total cash, cash equivalents and restricted cash, end of period 1,277.9 1,026.9 $ 1,442.1
Cash and cash equivalents held at Consolidated Funds $ 426.0 $ 228.8